RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY

被引：242
|
作者：
ELIAS, A
RYAN, L
SULKES, A
COLLINS, J
AISNER, J
ANTMAN, KH
机构：
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115
[2] UNIV MARYLAND,CTR CANC,DEPT ONCOL,BALTIMORE,MD 21201
[3] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 09期
关键词：
D O I：
10.1200/JCO.1989.7.9.1208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1208 / 1216
页数：9
相关论文
共 50 条
  • [1] RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA
    ANTMAN, KH
    RYAN, L
    ELIAS, A
    SHERMAN, D
    GRIER, HE
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 126 - 131
  • [2] Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas
    Pearl, ML
    Inagami, M
    McCauley, DL
    Valea, FA
    Chalas, E
    Fischer, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) : 745 - 748
  • [3] MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE CHEMOTHERAPY FOR OVARIAN MIXED MULLERIAN SARCOMA - REPORT OF 4 CASES
    PATSNER, B
    GREENBERG, S
    GYNECOLOGIC ONCOLOGY, 1995, 58 (03) : 386 - 388
  • [4] MESNA, DOXORUBICIN, IFOSFAMIDE, DACARBAZINE (MAID) REGIMEN FOR ADULTS WITH ADVANCED SARCOMA
    ELIAS, A
    RYAN, L
    AISNER, J
    ANTMAN, KH
    SEMINARS IN ONCOLOGY, 1990, 17 (02) : 41 - 49
  • [5] Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for treatment of metastatic or recurrent uterine leiomyosarcoma.
    Pant, Alok
    Lurain, John Robert
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience
    Ishiyama, Yudai
    Inakawa, Toru
    Yoshino, Maki
    Nishimura, Koichi
    Horiuchi, Toshihide
    Ishihara, Hiroki
    Toki, Daisuke
    Kondo, Tsunenori
    ANTICANCER RESEARCH, 2024, 44 (07) : 3213 - 3220
  • [7] Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: A report of two cases
    Minobe, Shinichiro
    Todo, Yukiharu
    Suzuki, Yoshihiro
    Aoyagi, Yukiko
    Umazume, Takeshi
    Okamoto, Kazuhira
    Kato, Hidenori
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (06) : 645 - 649
  • [8] Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney
    Yalcin, S
    Barista, I
    Tekuzman, G
    Gullu, I
    Firat, D
    JOURNAL OF UROLOGY, 1996, 155 (06): : 2024 - 2024
  • [9] DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE (AID) WITH MESNA UROPROTECTION FOR ADVANCED UNTREATED SARCOMA - A PHASE-I STUDY
    ELIAS, AD
    ANTMAN, KH
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 827 - 833
  • [10] Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
    Lee, Jiyun
    Jung, Hyun Ae
    Kim, Youjin
    Choi, Sangjoon
    Han, Joungho
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Sun, Jong-Mu
    LUNG CANCER, 2018, 122 : 160 - 164
12345